John Hancock Life Insurance Fit Review for People Living With HIV

Research Snapshot

Why John Hancock Qualified for This Study

Questions This Section Answers

• Is John Hancock a good choice for life insurance for people living with HIV?
• Why did John Hancock qualify for this HIV life insurance study when other carriers did not?

John Hancock qualified because it is one of the few major U.S. carriers with a publicly announced HIV underwriting program. John Hancock announced in 2016 that it would sell individual life insurance to eligible people with HIV, making it the second company in the United States to offer the coverage ^[4]. The company's own newsroom states it offers term and permanent life insurance to applicants living with HIV subject to a favorable and stable clinical course, strict adherence and response to antiretroviral therapy (ART), and the absence of significant immunosuppression or co-morbid conditions ^[5].

Six of seven platforms named John Hancock during the ranking stage: Anthropic, DeepSeek, Google, Grok, Kimi, and Perplexity. Its average listed rank was 3.0, with a best rank of 2 (Google and DeepSeek). One independent broker source describes John Hancock as the third most consistent company in approving policies for HIV applicants ^[7]. That ranking is broker-reported and has not been independently audited.

John Hancock also qualified because it offers both term and permanent life insurance categories, which matters for buyers who want to compare coverage structures rather than accept a single product type ^[9]. Its parent company is Manulife, and it holds an A+ rating from AM Best ^[11].

The Product, Model, Plan, or Service Most Relevant to Life Insurance for People Living With HIV

Questions This Section Answers

• Which John Hancock plan should a buyer living with HIV choose if they need term or permanent coverage?
• Does John Hancock offer whole life insurance to HIV-positive applicants, or only term and universal life?

The most relevant John Hancock products for this use case are fully underwritten term life insurance and permanent life insurance, including eligible policies with the John Hancock Vitality Program. HIV eligibility and pricing depend on current underwriting criteria ^[13].

Platforms described the relevant product set slightly differently. Anthropic listed term life plus Universal Life, Indexed Universal Life, and Variable Universal Life, and stated that whole life is not currently offered ^[15]. Kimi described term and permanent life including whole life and universal life ^[17]. Perplexity referenced term, whole life, variable UL, and indexed UL ^[18]. This is a genuine conflict in the supplied evidence: some sources say whole life is unavailable, others list it. Buyers should confirm the exact product lineup in their state before applying.

Term lengths reported by platforms include 10, 15, 20, and 30 years, with the 30-year option not available in New York ^[15]. Grok reported 10/15/20-year term with a $750,000 minimum face amount and universal life ^[19]. Kimi reported term minimums of $750,000 and permanent minimums of $250,000 ^[20]. These figures come from broker and review sources, not from a verified John Hancock rate filing.

The Vitality wellness program is attached to John Hancock life insurance policies. Vitality GO is included at no additional cost, and Vitality PLUS is a paid upgrade that offers access to more rewards, including up to 25% in annual life insurance premium savings ^[21]. Whether Vitality rewards apply to HIV-rated policies is not clearly established in the sources reviewed ^[18].

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about John Hancock life insurance for people living with HIV?
• Is John Hancock's HIV life insurance program still active in 2026?

Platforms agreed on several core points.

First, John Hancock publicly offers life insurance to people living with HIV. The company's 2016 announcement is cited across Anthropic, Perplexity, and Google research ^[24]. No platform found evidence that the program has been withdrawn.

Second, the program is fully underwritten, not simplified or guaranteed issue. Platforms consistently described an informal application with medical records, an attending physician statement, and lab review ^[27]. DeepSeek noted that John Hancock's public materials do not establish an HIV-specific guaranteed-issue pathway ^[30].

Third, eligibility is age-banded. Multiple platforms reported an age range of 30 to 65 ^[31]. This is narrower than at least one competitor: Guardian publicly states eligibility starting at age 20 ^[33].

Fourth, coverage is capped. Platforms reported a maximum face amount of $2,000,000 for HIV-positive applicants ^[31]. Guardian publishes a $10,000,000 maximum for term and whole life ^[34].

Fifth, approved HIV applicants typically receive substandard ratings. Broker sources describe standard non-tobacco Table 8 with a $2.00 flat extra monthly premium as the common outcome ^[35]. Perplexity reported table ratings of roughly 250% to 400% with a $2 flat extra for younger ages ^[36].

Where the AI Platforms Disagreed or Were Uncertain

Platforms disagreed or were uncertain on several material points.

Whether John Hancock currently accepts HIV-positive applicants under fully underwritten policies. OpenAI stated that John Hancock's public materials do not clearly state whether fully underwritten term or permanent policies accept HIV-positive applicants, and that the recommended product label including HIV underwriting is not independently verified by John Hancock's reviewed public pages ^[37]. DeepSeek reached a similar conclusion, reporting that no current John Hancock HIV underwriting guideline, rate table, or eligibility statement was found in its reviewed public sources ^[39]. Anthropic, Google, Grok, Kimi, and Perplexity, by contrast, treated the HIV program as active and described specific criteria.

Exact clinical thresholds. Anthropic, Grok, Kimi, and Google reported specific figures: 5+ years since diagnosis, 36 months on ART, 30 months undetectable viral load, CD4 >350, physician visits every 6 months, no tobacco, no hepatitis history, no AIDS-defining conditions, and no HIV acquired via transfusion or IV drug use ^[40]. Perplexity reported similar but not identical criteria, including five years of favorable treatment and ratings from 250% to 400% ^[43]. OpenAI stated that John Hancock does not publicly disclose its current HIV thresholds for viral load, CD4 count, treatment duration, adherence, AIDS-defining conditions, or medical follow-up ^[38]. These specific thresholds are broker- and review-reported, not confirmed by a verified John Hancock underwriting bulletin.

Whether whole life is offered. Anthropic and U.S. News state whole life is not available ^[45]. Kimi and Perplexity list whole life among available products ^[46]. This conflict is unresolved in the supplied evidence.

Vitality savings magnitude. Anthropic reported up to 25% in annual premium savings ^[48]. OpenAI reported that Vitality premium savings vary by underwriting status, age, policy type, terms, and Vitality status ^[49]. The exact cap and realistic savings for an HIV-rated policyholder are not established.

Whether the 2016 announcement reflects 2026 guidelines. Anthropic noted that the 2016 announcement remains current as of 2026 in all found sources, but no recent 2025–2026 policy update explicitly confirms continued or unchanged underwriting ^[50]. Perplexity noted that public sources disagree on details such as term minimum face amount and exact viral load language ^[43].

New York licensing. OpenAI reported that the exact issuing company may vary by state, that John Hancock states its U.S. and New York life insurance companies issue products, and that the U.S. company is not licensed in New York ^[38]. Anthropic similarly noted that John Hancock is not licensed in New York and that applicants there must use an alternative carrier or John Hancock of New York ^[51].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What features does John Hancock offer that matter for a buyer living with HIV?
• Does the John Hancock Vitality program help HIV-positive policyholders reduce premiums?

The features most relevant to this use case are the HIV underwriting pathway, the term and permanent product range, the Vitality wellness program, and the informal-review process.

HIV underwriting pathway. John Hancock's public announcement describes coverage for applicants living with HIV ages 30 to 65 for face amounts up to $2,000,000, subject to favorable and stable clinical course, strict adherence and response to ART, and absence of significant immunosuppression or co-morbid conditions ^[52]. Independent reviews state that John Hancock considers viral load, CD4 count, and time since diagnosis ^[54].

Product range. Term life options reported include 10, 15, 20, and 30 years, with 30-year not available in New York ^[55]. Permanent options reported include Universal Life, Indexed Universal Life, and Variable Universal Life ^[55]. Grok reported 10/15/20-year term plus universal life ^[57].

Vitality wellness program. All John Hancock life insurance policies come with the Vitality program, which rewards customers for everyday healthy activities such as walking the dog, going to the doctor, and buying healthy food ^[58]. Vitality GO is included at no additional cost; Vitality PLUS is a paid upgrade offering access to more rewards, including up to 25% in annual life insurance premium savings ^[59]. Members earn points for everyday healthy choices, from staying active to keeping up with preventative care ^[60]. Whether HIV status affects Vitality eligibility or rewards structure is not confirmed in the sources reviewed ^[61].

Informal review process. Broker sources describe an informal application with medical records upfront for review before formal application, which may reduce unnecessary hard inquiries or declined applications ^[61]. Google reported that applications begin with an informal inquiry accompanied by an Attending Physician Statement and detailed medical records from an HIV specialist ^[62].

Conversion privilege. Anthropic reported that term policies may be convertible to permanent coverage before age 70 or the end of the level premium period, without new medical underwriting ^[55]. OpenAI stated that some John Hancock term policies may be convertible to permanent coverage, but eligibility and timing depend on the specific policy terms ^[63].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does John Hancock life insurance cost per month for an HIV-positive applicant?
• What fees and ratings apply to John Hancock HIV life insurance policies?

No reliable public John Hancock premium quote for a person living with HIV was identified ^[64]. Pricing depends on age, state, coverage amount, policy type, underwriting classification, medical history, and policy features.

Standard-applicant benchmark pricing. For non-HIV applicants, a $100,000 John Hancock term policy costs $9 a month for women and $11 a month for men, based on a 40-year-old nonsmoker in average health with a 20-year term — 40% to 43% below the national average. At $1.5 million and $2 million coverage levels, rates are 6% to 7% above average ^[65]. Average annual premium across all John Hancock policies is $349, versus an industry average of $382 ^[65].

HIV-rated pricing. Broker sources report that most HIV underwriting offers are standard non-tobacco Table 8 with a $2.00 flat extra monthly premium ^[66]. Perplexity reported table ratings of roughly 250% to 400% with a $2 flat extra for younger ages ^[69]. Grok published illustrative monthly premiums for males: age 40, $750K term approximately $372 ^[67]. Kimi published sample monthly premiums: male age 30, $750K = $286 and $1M = $377; age 40, $750K = $372 and $1M = $490; age 50, $750K = $688 and $1M = $890; age 60, $750K = $1,436 and $1M = $1,911. Female rates are lower: age 30, $750K = $265 and $1M = $350; age 40, $750K = $325 and $1M = $426 ^[68]. These are illustrative from one broker source and actual offers vary.

Vitality fees. For John Hancock term policies with the optional Vitality rider, Vitality PLUS costs 3% of annual premium ^[70]. For single-life permanent products, the Vitality rider fee is reported as $2 per month; availability and applicability depend on the policy and state ^[70]. Vitality may involve additional out-of-pocket costs for optional products such as the Apple Watch program, including an initial payment, monthly payments, taxes, and possible upgrade fees ^[70].

Contract terms. Term options are 10, 15, 20, or 30 years, with 30-year not available in New York ^[71]. Conversion privilege allows term-to-permanent conversion before age 70 or end of the level premium period ^[71]. Permanent policies are guaranteed to mid-80s to early 90s, with the exact guarantee period varying by product type ^[71]. Surrender charges apply to permanent policies within early years, and policy loans or withdrawals reduce death benefit ^[71]. No HIV-specific cancellation, conversion, contestability, or re-underwriting terms were verified from the reviewed public sources ^[64].

Best Suited For

Questions This Section Answers

• Who is John Hancock best suited for among HIV-positive life insurance buyers?
• What coverage amount and age range fit John Hancock's HIV underwriting best?

John Hancock is best suited for applicants living with HIV who meet strict clinical criteria and want fully underwritten term or permanent coverage.

Platforms converged on these buyer profiles:

• Applicants ages 30 to 65 ^[72].
• Applicants with 5+ years since diagnosis and 36+ months on antiretroviral therapy ^[73].
• Applicants with undetectable viral load for 30+ months and CD4 consistently above 350 ^[73].
• Applicants with no tobacco use, no hepatitis history, no AIDS-defining conditions, and no HIV acquired via transfusion or IV drug use ^[73].
• Applicants seeking $100,000 to $1 million in coverage, where John Hancock term pricing is most competitive ^[76].
• Applicants motivated to engage with wellness tracking and interested in Vitality premium discounts ^[77].
• Applicants willing to complete full medical underwriting and provide HIV-related clinical information ^[79].

Anthropic specifically noted that John Hancock's fit is strongest for motivated wellness-focused applicants in the 30–50 age range seeking $250,000 to $1 million coverage who value the Vitality program's health tracking and premium reductions ^[77].

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose John Hancock for life insurance while living with HIV?
• What medical or lifestyle factors disqualify a buyer from John Hancock's HIV underwriting?

John Hancock is probably not the best fit for several buyer profiles.

• Applicants seeking coverage above $2 million. Prudential, AIG/Corebridge, or Pacific Life may offer $5–10 million capacity ^[81].
• Applicants younger than 30 or older than 65. Guardian extends lower and upper age boundaries ^[83].
• Applicants with newly diagnosed HIV or less than 6 months of stable treatment. Most carriers prefer a 6–12 month stability window ^[85].
• Applicants with AIDS-defining illness or CD4 below 200. Guaranteed issue or simplified-issue products may be the only path ^[87].
• Applicants who use tobacco. Tobacco use is not allowed for HIV-positive applicants under John Hancock's reported criteria ^[88].
• Applicants with hepatitis B or C history, diabetes, coronary artery disease, or a history of IV drug use ^[90].
• Applicants seeking guaranteed approval or simplified-issue coverage. John Hancock's published Simple Term with Vitality eligibility document lists HIV/AIDS as not eligible ^[91].
• Applicants who want whole life insurance, if the 2026 reviews stating whole life is unavailable are correct ^[93].
• Applicants in New York State, where the main John Hancock entity is not licensed ^[94].
• Applicants uninterested in or unable to engage with wellness tracking, since Vitality discounts will not apply ^[96].
• Applicants seeking agent-free or fully digital underwriting. John Hancock requires agent involvement and a paramedical exam ^[97].

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to John Hancock for an HIV-positive buyer who needs more than $2 million in coverage?
• When should a buyer choose Guardian or Prudential instead of John Hancock for HIV life insurance?

Another option may be better in these situations:

• Higher coverage needs. Prudential, AIG/Corebridge, or Pacific Life may offer $5–10 million capacity ^[99].
• Younger or older applicants. Guardian permits ages 20+ and offers up to $10 million ^[101].
• Shorter treatment history. Guardian requires 2+ years on HAART, versus John Hancock's reported 36 months ^[101].
• Lowest premiums at $500K+ coverage. Banner Life (Table 2 approvals), Pacific Life, or Prudential are typically better for high-amount cases ^[99].
• Newly diagnosed HIV (under 6 months of treatment). Some carriers may have more flexible stability windows; guaranteed issue products remain available regardless ^[103].
• AIDS-defining illness or CD4 <200. Guaranteed issue or simplified-issue products only; John Hancock full underwriting likely unavailable ^[104].
• Whole life insurance specifically. If John Hancock does not offer whole life, consider Guardian, Prudential, or other carriers ^[105].
• Significant co-morbidities. Prudential or specialized impaired-risk carriers may be more accommodating ^[99].
• New York State. Must use John Hancock of New York or an alternative carrier ^[106].
• No wellness engagement. Competitors without mandatory wellness components may be a better fit ^[108].
• Agent-free or fully digital underwriting. Accelerated-underwriting carriers may streamline the process ^[109].
• Guaranteed-issue or simplified-issue needs. A carrier with a published HIV program may be easier to evaluate ^[110].

OpenAI specifically recommended comparing John Hancock with a carrier such as Guardian that publicly states HIV-specific eligibility criteria ^[110]. Anthropic recommended using a broker experienced in HIV underwriting to compare John Hancock against Prudential, Banner Life, Pacific Life, and Guardian ^[99].

Questions to Verify Before Buying

Buyers should confirm the following with John Hancock or an experienced independent broker before submitting an application:

1. Does John Hancock currently consider HIV-positive applicants for the specific fully underwritten term or permanent policy being proposed in the buyer's state? ^[111]
2. What current underwriting requirements apply to HIV, including treatment duration, adherence, viral load, CD4 count and nadir, AIDS-defining conditions, coinfections, other health conditions, and specialist follow-up? ^[111]
3. Will the application require an HIV test, medical records, attending-physician statement, prescription-history review, or additional laboratory testing? ^[111]
4. What offer classes, exclusions, coverage limits, postponement rules, or decline rules apply to the buyer's medical profile? ^[111]
5. Will the buyer be considered through accelerated underwriting, or will a full medical examination and records review be required? ^[114]
6. What is the guaranteed premium schedule, and what are the policy's conversion, lapse, reinstatement, contestability, and nonforfeiture provisions? ^[111]
7. What is the exact Vitality fee for this policy, is participation optional, and can rewards or premium savings change or end? ^[117]
8. Are all desired riders, policy types, face amounts, and conversion rights available in the buyer's state? ^[111]
9. How does the proposed John Hancock offer compare with at least two carriers that publish or routinely handle HIV-specific underwriting? ^[119]
10. Can the agent provide the policy illustration, specimen contract, underwriting class, and all recurring charges before the buyer submits an application? ^[111]
11. Does John Hancock's current underwriting still limit HIV-positive applicants to ages 30–65, and have age boundaries been extended in 2025–2026? ^[112]
12. What are the exact viral load thresholds and minimum CD4 count required for standard or substandard approval? ^[121]
13. How long must the buyer demonstrate stable ART and undetectable viral load before qualifying — 6 months, 1 year, 2+ years? ^[123]
14. If declined, can the buyer reapply later after establishing longer treatment stability? Is there a waiting period or reapplication fee? ^[123]
15. Is the $2 million face amount maximum firm, or can it be exceeded with additional underwriting or medical records? ^[112]
16. How transparent is John Hancock about exact Vitality premium savings for the buyer's specific policy type, coverage, and age? ^[125]
17. Are there any state-specific limitations or differences in underwriting? ^[111]
18. If the buyer's health status declines post-underwriting, can John Hancock modify or cancel the policy? ^[111]

Final AI Consensus Verdict

John Hancock is a mixed-to-good fit for life insurance for people living with HIV. Five of seven platforms rated it "good," one rated it "mixed," and one rated it "uncertain." The strongest case for John Hancock is its publicly announced HIV underwriting program, which offers fully underwritten term and permanent coverage to applicants ages 30–65 up to $2,000,000, subject to strict clinical criteria ^[126]. The Vitality wellness program is a distinctive feature that can reduce premiums for engaged policyholders ^[128].

The main limitations are the absence of publicly verified current HIV thresholds, the explicit HIV exclusion for Simple Term with Vitality ^[130], the $2 million coverage cap, the age band of 30–65, the tobacco and hepatitis exclusions, and the reported Table 8 plus $2 flat extra pricing that makes John Hancock more expensive than standard-risk coverage ^[131]. John Hancock is not the market leader for HIV underwriting; Prudential consistently ranks first, and Banner Life and Pacific Life may offer better rates at higher coverage amounts ^[134].

Buyers should verify current exact underwriting criteria directly with an agent, as publicly available information lacks specificity and may not reflect real-time guidelines ^[136]. A broker experienced in HIV underwriting can compare John Hancock against Prudential, Banner Life, Pacific Life, and Guardian for the buyer's specific health profile and coverage need ^[134].

For a broader view of how carriers compare across this use case, see the Life Insurance for People Living With HIV consensus index. Buyers who want to compare other high-risk categories can browse the life insurance directory.

How This Review Was Produced

This review was produced from platform-reported research collected on 2026-09-22. Seven AI platforms evaluated John Hancock for the use case "Life Insurance for People Living With HIV": Anthropic (claude-haiku-4-5-20251001), DeepSeek (deepseek-v4-flash), Google (gemini-3.5-flash), Grok (x-ai/grok-4.3), Kimi (moonshotai/kimi-k2.6), OpenAI (gpt-5.6-luna), and Perplexity (perplexity/sonar). Six of seven platforms named John Hancock during the ranking stage.

Each platform supplied its own fit assessment, use-case findings, pricing and terms, limitations, and questions to verify before buying. The writer stage did not independently verify any platform claim. Citations are platform-reported evidence, not independently verified facts. No-search model claims require explicit verification before being described as current facts.

Methodology Limitations

Several limitations apply to this review.

• The supplied URLs were collected from platform responses and were not independently validated by the writer stage.
• Platform-reported research dates differ from the authoritative run date. DeepSeek's research date was 2026-05-09; all other platforms reported 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.
• Official-site retrieval failed for one or more mentions; no failed fetch was used as a verified domain key. Identity used exact-name fallback; the matching reported domain was retained for downstream research but remains unverified.
• All included platforms evaluated fit, but platform_mentions counts only platforms that named the entity during ranking discovery.
• Conflicting product names, pricing, and capabilities were not resolved by guessing. Buyers should verify conflicts directly.
• The deterministic identity audit contains qualification notes that are disclosed where relevant.
• Exact HIV underwriting thresholds, current 2026 guidelines, and HIV-specific pricing are not publicly verified. Broker and review sources may be outdated.
• The claim that John Hancock is the "third most consistent" carrier for HIV approvals is sourced from advisor and review sites, not a carrier-agnostic study.
• Whether John Hancock's HIV program has changed, expanded, or contracted since its 2016 launch is not documented in recent sources.
• Geographic availability of HIV-specific underwriting across all U.S. states is not specified in the reviewed sources.